✦ LIBER ✦

6521 POSTER Is pemetrexed more effective in patients with non-squamous histology? A retrospective analysis of a phase III trial of pemetrexed vs docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Peterson, P.; Park, K.; Fossella, F.; Gatzemeier, U.; John, W.; Scagliotti, G.

Book ID: 122683296
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 75 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(07)71349-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

57 Pemetrexed vs docetaxel: a phase III

57 Pemetrexed vs docetaxel: a phase III study in patients with advanced non-small cell lung cancer (NSCLC) who were previously treated with chemotherapy

✍ C. Manegold; R. Gervais; K. Aigner; C. Desch; H. Lim; K. Szondy; C. Bagnes; S. P 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 161 KB

PL-5 A phase III study of pemetrexed vs.

PL-5 A phase III study of pemetrexed vs. docetaxel in patients with advanced non-small-cell lung cancer (NSCLC) who were previously treated with chemotherapy

✍ Shepherd, Frances A.; Pereira, Jose R.; Von Pawel, Joachim; Gatzemeier, Ulrich; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Randomized Phase III Trial of Pemetrexed

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

✍ Hanna, N.; Shepherd, F. A.; Fossella, F. V.; Pereira, J. R.; De Marinis, F.; von 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 229 KB

9004 Vandetanib plus pemetrexed vs pemet

9004 Vandetanib plus pemetrexed vs pemetrexed as 2nd-line therapy in patients with advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

✍ Vansteenkiste, J.; Arrieta, O.; Gottfried, M.; Blackhall, F.H.; Raats, J.; Yang, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A phase II study of pemetrexed in patien

A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001)

✍ Hattori, Yoshihiro; Satouchi, Miyako; Katakami, Nobuyuki; Fujita, Shiro; Kaji, R 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 244 KB

9083 POSTER Pemetrexed (PEM) Plus Platin

9083 POSTER Pemetrexed (PEM) Plus Platinum-based Regimen as First Line Treatment in Unselected Patients Affected With Non-squamous Non-small-cell Lung Cancer (NSCLC): a Retrospective Multicenter Analysis

✍ Moscetti, L.; Fabbri, M.A.; Narducci, F.; Mansueto, G.; Longo, F.; Martelli, O.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB